» Articles » PMID: 38264224

The Predictive Role of Serum Uric Acid Levels Before Pregnancy in the Development of Gestational Diabetes Mellitus

Overview
Journal Diabetol Int
Specialty Endocrinology
Date 2024 Jan 24
PMID 38264224
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: With the prevalence of obesity, growing age of first pregnancy, highly processed high-calorie diet, consumption of saturated fats as well as sedentary and stressful life, the prevalence of gestational diabetes mellitus (GDM) is increasing. We aimed to determine the predictive role of pre-pregnancy serum uric acid levels and the occurrence of GDM during pregnancy.

Methods: This study was a descriptive-analytical study that was performed retrospectively through case-control. The Subjects of this study were women over 18 years of age who were 24-28 weeks pregnant. All subjects of this study were evaluated for GDM based on the ADA guideline and were divided into case and control groups. All data relating to the period of 6 months before pregnancy of the study participants including blood uric acid level, blood pressure, etc. were collected and analyzed.

Results: In this study, 454 normal individuals without GDM and 478 others with GDM were examined. The mean serum uric acid showed to be 4.47 ± 1.33 mg/dl in patients with GDM but 3.7 ± 1.25 mg/dl in patients without GDM ( value = 0.001). The results of the regression test showed that the incidence of GDM in people with blood uric acid levels of 4.1-5, 5.1-6, and more than 6 mg/dl is 2.46, 3.42, and 4.9 times higher in people with uric acid levels less than 3 mg/dl, respectively.

Conclusion: The present study identified that serum uric acid levels in the period of 6 months before pregnancy can be used as an independent predictor marker for future GDM.

Citing Articles

Investigating predictive factors in treatment response with metformin in patients with gestational diabetes mellitus: a cross-sectional analytical-descriptive study.

Ghanei A, Fattahi M, Banadkoki M J Diabetes Metab Disord. 2024; 24(1):5.

PMID: 39697861 PMC: 11649588. DOI: 10.1007/s40200-024-01520-5.

References
1.
Damm P . Future risk of diabetes in mother and child after gestational diabetes mellitus. Int J Gynaecol Obstet. 2009; 104 Suppl 1:S25-6. DOI: 10.1016/j.ijgo.2008.11.025. View

2.
Nakagawa T, Tuttle K, Short R, Johnson R . Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol. 2006; 1(2):80-6. DOI: 10.1038/ncpneph0019. View

3.
Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck M . Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension. 2003; 42(4):474-80. DOI: 10.1161/01.HYP.0000091371.53502.D3. View

4.
King H . Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age. Diabetes Care. 1998; 21 Suppl 2:B9-13. View

5.
Perlstein T, Gumieniak O, Williams G, Sparrow D, Vokonas P, Gaziano M . Uric acid and the development of hypertension: the normative aging study. Hypertension. 2006; 48(6):1031-6. DOI: 10.1161/01.HYP.0000248752.08807.4c. View